The U.S. Food and Drug Administration has officially implemented a major update to its quality system requirements for medical device manufacturers. As of February 2, 2026, the new Quality Management System Regulation (QMSR) is now in effect, marking the first significant overhaul of 21 CFR Part 820 in decades.
The QMSR replaces the former Quality System Regulation by incorporating ISO 13485:2016 directly by reference. This alignment brings the FDA’s expectations in line with internationally recognized standards, reducing unnecessary duplication and modernizing the regulatory landscape for medical device quality management.
A Shift to a Modernized, Globally Aligned Framework
Under the new rule, FDA has also adopted a revised inspection program: the Inspection of Medical Device Manufacturers Compliance Program 7382.850. This updated approach aligns with the principles of ISO 13485:2016 and replaces the longstanding QSIT methodology.
The intent behind these changes is clear:
- Streamline compliance for global manufacturers
- Strengthen risk‑management practices
- Improve transparency throughout the device lifecycle
- Maintain alignment with the FD&C Act where required
Together, these updates bring U.S. and international regulatory expectations closer than ever before.
What This Means for Delta Development Team Customers
For DDT customers, this transition is seamless.
Delta Development Team’s quality management system is already fully aligned with ISO 13485:2016. Because the new QMSR is built around that same standard, no action is required on your end. There is no need to update documentation, revise procedures, revalidate processes, or adjust any part of your current quality system activities.
In short: you can continue operating exactly as you do today. DDT’s existing framework already meets the updated regulatory expectations, ensuring uninterrupted compliance under the new FDA rule.
If you have questions about the QMSR, FDA inspections, or how these changes fit into your compliance strategy, our team is here to help. We’re committed to supporting you through every step of the evolving regulatory landscape.